Key biomarkers to monitor would include a comprehensive metabolic panel (CMP), a lipid panel (cholesterol, triglycerides), and especially liver function tests (ALT, AST, GGT)
Psychosomatic Medicine 61(5):591-598
Gaspari T, Welungoda I, Widdop RE, Simpson RW, Dear AE (2013) The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE -/- mouse model
V.VittinghoffE.BauerD
Most patients begin to see resultssuch as improved energy, reduced appetite, and weight losswithin a few weeks
When glutathione levels are depleted, these immune responses become less efficient